Nature Communications (Feb 2023)
Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system
Abstract
Inhibition of 15-prostaglandin dehydrogenase (15-PGDH) is a promising therapeutic target for regenerative medicine. We report the structure of 15-PGDH in complex with two different inhibitors. Unexpectedly, access to the binding pocket is regulated by a dynamic “lid” of the enzyme.